Nutra Pharma Corp., (OTC BB: NPHC) a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has announced that Designer Diagnostics, a wholly owned subsidiary of Nutra Pharma, has received orders from Dr. V. M. Katoch for the NTM Diagnostic TestKits designed for the rapid identification of NonTuberculosis Mycobacterium (NTM). Dr. Katoch is the director of the Central JALMA Institute of Leprosy and other Mycobacterial Diseases. The Institute was founded in 1976 and is currently a leading institute for leprosy and mycobacterial research.
